Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Gavvovidis, Ioannis Dr. (1) Kettenmann, Helmut Prof. Dr. (1) Kieback, Elisa Dr. (1) Leisegang, Matthias Dr. (4) Poncette, Lucia (1) Uckert, Wolfgang Prof. Dr. (10) (-) Blankenstein, Thomas Prof. Dr. (5) (-) Lorenz, Felix Dr. (3) 1998 (2) 2000 (2) 2003 (4) 2004 (1) 2005 (3) 2006 (2) 2007 (1) 2008 (1) 2010 (1) (-) 2011 (2) 2014 (1) (-) 2015 (3) 2016 (2) 2017 (2) 2018 (1) (-) 2019 (2) Bioinformatics (1) Biology of Malignant Lymphomas (11) Genetics and Genomics of Cardiovascular Diseases (1) (-) Molecular Cell Biology and Gene Therapy (7) Molecular Immunology and Gene Therapy (14) Molecular Immunotherapy (3) Proteome Dynamics (1) Signal Transduction in Tumor Cells (1) Structural Biology of Membrane-Associated Processes (1) Systems Biology of Gene Regulatory Elements (1) 7 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Lorenz, Felix Dr.Molecular Cell Biology and Gene Therapy201120152019 Sort: Result score Newest to oldest Oldest to newest January 02, 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein January 01, 2019 in Cancer Immunol Res Mapping the MHC class I spliced immunopeptidome of cancer cells J. Liepe J. Sidney F.K.M. Lorenz A. Sette M. Mishto April 01, 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber April 01, 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein March 23, 2015 in PLoS ONE Codon optimization of the human papillomavirus E7 oncogene induces a CD8(+) T cell response to a cryptic epitope not harbored by wild-type E7 F.K.M. Lorenz S. Wilde K. Voigt E. Kieback B. Mosetter D.J. Schendel W. Uckert July 28, 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein January 15, 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
January 02, 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein
January 01, 2019 in Cancer Immunol Res Mapping the MHC class I spliced immunopeptidome of cancer cells J. Liepe J. Sidney F.K.M. Lorenz A. Sette M. Mishto
April 01, 2015 in Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
April 01, 2015 in Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
March 23, 2015 in PLoS ONE Codon optimization of the human papillomavirus E7 oncogene induces a CD8(+) T cell response to a cryptic epitope not harbored by wild-type E7 F.K.M. Lorenz S. Wilde K. Voigt E. Kieback B. Mosetter D.J. Schendel W. Uckert
July 28, 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
January 15, 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
